Failure to Treat Life-Threatening Ventricular Tachyarrhythmias in Contemporary Implantable Cardioverter-Defibrillators: Implications for Strategic Programming [Original Articles]

Conclusions: Complex and unanticipated interactions between manufacturer-specific features and generic programming can prevent therapy for VF. More data are needed to assess the risks and benefits of translating evidence-based detection parameters from one manufacturer to another.

http://circep.ahajournals.org/cgi/content/short/10/9/e005305?rss=1

Source: Circulation: Arrhythmia and Electrophysiology - September 15, 2017 Category: Cardiology Authors: Thogersen, A. M., Larsen, J. M., Johansen, J. B., Abedin, M., Swerdlow, C. D. Tags: Catheter Ablation and Implantable Cardioverter-Defibrillator, Sudden Cardiac Death, Ventricular Fibrillation Original Articles Source Type: research